HK1157182A1 - Immunological composition - Google Patents

Immunological composition

Info

Publication number
HK1157182A1
HK1157182A1 HK11111405.3A HK11111405A HK1157182A1 HK 1157182 A1 HK1157182 A1 HK 1157182A1 HK 11111405 A HK11111405 A HK 11111405A HK 1157182 A1 HK1157182 A1 HK 1157182A1
Authority
HK
Hong Kong
Prior art keywords
immunological composition
immunological
composition
Prior art date
Application number
HK11111405.3A
Other languages
English (en)
Chinese (zh)
Inventor
Philip Ralph Lehrbach
William John Cheshire
Zhixian Xin
Original Assignee
佐蒂斯 有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008904261A external-priority patent/AU2008904261A0/en
Application filed by 佐蒂斯 有限責任公司 filed Critical 佐蒂斯 有限責任公司
Publication of HK1157182A1 publication Critical patent/HK1157182A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK11111405.3A 2008-08-19 2011-10-24 Immunological composition HK1157182A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008904261A AU2008904261A0 (en) 2008-08-19 Immunological Composition
US9209108P 2008-08-27 2008-08-27
PCT/US2009/054285 WO2010022135A1 (fr) 2008-08-19 2009-08-19 Composition immunologique

Publications (1)

Publication Number Publication Date
HK1157182A1 true HK1157182A1 (en) 2012-06-29

Family

ID=41696586

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11111405.3A HK1157182A1 (en) 2008-08-19 2011-10-24 Immunological composition

Country Status (17)

Country Link
US (1) US20100047279A1 (fr)
EP (1) EP2331126A1 (fr)
JP (1) JP2012500282A (fr)
KR (1) KR101320141B1 (fr)
CN (1) CN102186502B (fr)
AR (1) AR076437A1 (fr)
AU (1) AU2009282581B2 (fr)
BR (1) BRPI0917290A8 (fr)
CA (1) CA2734654C (fr)
CO (1) CO6341568A2 (fr)
HK (1) HK1157182A1 (fr)
MX (1) MX2011001910A (fr)
RU (1) RU2506094C2 (fr)
TW (1) TW201010719A (fr)
UA (1) UA101385C2 (fr)
WO (1) WO2010022135A1 (fr)
ZA (1) ZA201102082B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011043962A2 (fr) * 2009-10-07 2011-04-14 Wyeth Llc Compositions comprenant un adjuvant, un macrolide et un antigène protéique et procédés d'utilisation de celles-ci
CA2792117C (fr) * 2010-03-12 2016-09-20 Merial Limited Vaccins de recombinaison contre le virus de la fievre aphteuse et utilisations de ceux-ci
WO2012154739A1 (fr) * 2011-05-09 2012-11-15 Uwm Research Foundation, Inc. Utilisation de cyclodextrines dans des régimes, de l'eau ou des adjuvants de vaccins pour améliorer le système immunitaire d'un poisson
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
WO2015057777A1 (fr) 2013-10-17 2015-04-23 Zoetis Llc Méthodes et compositions pour le traitement d'une infection à s. equi
WO2015179840A1 (fr) * 2014-05-23 2015-11-26 Phibro Animal Health Corporation Combinaison, composition et méthode d'administration de la combinaison ou de la composition à des animaux

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295749A1 (fr) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides comme stimulateurs du mécanisme de défense non spécifique
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
ES2500490T3 (es) * 1997-08-29 2014-09-30 Antigenics Inc. Composiciones que comprenden el adyuvante QS-21 y polisorbato o ciclodextrina como excipiente
WO2000009159A1 (fr) * 1998-08-10 2000-02-24 Aquila Biopharmaceuticals, Inc. Compositions de cpg et d'adjuvants a base de saponine et leurs procedes d'utilisation
EP1104767A1 (fr) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Dérivés de mono- et disaccharides contenant esters d'acides gras et esters de sulfate
EP1434859A2 (fr) * 2001-07-25 2004-07-07 New York University Utilisation de glycosylceramides comme adjuvants pour des vaccins contre les infections et le cancer
WO2005079842A1 (fr) * 2004-02-20 2005-09-01 China Agricultural University Adjuvant immunologique
JP2008502605A (ja) * 2004-06-16 2008-01-31 スマート ドラッグ システムズ インコーポレイティド 徐放性ワクチン組成物
RU2288007C2 (ru) * 2005-02-17 2006-11-27 ГНУ ВНИИ ветеринарной вирусологии и микробиологии Способ изготовления ассоциированной инактивированной культуральной вакцины против инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота

Also Published As

Publication number Publication date
CA2734654C (fr) 2015-02-10
CN102186502A (zh) 2011-09-14
BRPI0917290A2 (pt) 2015-11-10
CA2734654A1 (fr) 2010-02-25
ZA201102082B (en) 2011-11-30
CN102186502B (zh) 2014-07-16
TW201010719A (en) 2010-03-16
AU2009282581B2 (en) 2013-12-19
EP2331126A1 (fr) 2011-06-15
WO2010022135A1 (fr) 2010-02-25
KR101320141B1 (ko) 2013-11-13
MX2011001910A (es) 2011-06-20
UA101385C2 (ru) 2013-03-25
KR20110044791A (ko) 2011-04-29
AU2009282581A1 (en) 2010-02-25
US20100047279A1 (en) 2010-02-25
AR076437A1 (es) 2011-06-15
BRPI0917290A8 (pt) 2016-11-01
CO6341568A2 (es) 2011-11-21
RU2011105863A (ru) 2012-09-27
RU2506094C2 (ru) 2014-02-10
JP2012500282A (ja) 2012-01-05

Similar Documents

Publication Publication Date Title
GB0815022D0 (en) Composition
GB0819633D0 (en) Composition
GB0818473D0 (en) Composition
GB0822246D0 (en) Composition
GB0801119D0 (en) Composition
GB0810554D0 (en) Herbicde composition
GB0809808D0 (en) Composition
GB0818472D0 (en) Composition
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
EP2357204A4 (fr) Composition
GB0810359D0 (en) Composition
GB0801836D0 (en) Novel composition
ZA201102329B (en) Novel composition
HK1157182A1 (en) Immunological composition
GB0817656D0 (en) Composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
GB0818269D0 (en) Composition
GB0818231D0 (en) Composition
GB0813589D0 (en) Composition
GB0809983D0 (en) Composition
GB0823344D0 (en) Composition
GB0821754D0 (en) Composition
GB0804031D0 (en) Composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180819